Category: Market News

Experian plc (LSE:EXPN) delivered a robust start to fiscal year 2025, reporting a 12% year-over-year increase in total revenue at constant currency, along with 8% organic revenue growth. This performance reflects the company’s continued focus on innovation, strategic acquisitions, and geographic diversification.

North America led the way with strong growth across both its B2B operations and Consumer Services division. Latin America also posted impressive results, with a 17% revenue boost, largely driven by targeted acquisitions. Meanwhile, the UK and Ireland registered steady progress, and the EMEA and Asia Pacific regions benefited from the successful integration of illion, enhancing Experian’s reach and capabilities in those markets.

These results reinforce Experian’s strong competitive position and its commitment to expanding its data and technology solutions across high-growth markets.

The company’s outlook remains positive, supported by healthy fundamentals and forward-looking strategic initiatives. However, its elevated valuation may cap short-term upside. Technical indicators suggest stable momentum, pointing to a well-supported market position.

About Experian plc

Experian is a global leader in data and analytics, offering technology-driven solutions that empower individuals and businesses to make informed decisions. Its services span credit reporting, fraud prevention, healthcare optimization, digital marketing, and automotive data insights. Listed on the FTSE 100, Experian is headquartered in Dublin, Ireland, and operates in multiple industries including finance, insurance, healthcare, and automotive, with a footprint across North America, Latin America, EMEA, and Asia Pacific.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Eagle Eye Solutions Group PLC (LSE:EYE) delivered a strong performance in the second half of fiscal year 2025, with total revenue edging up 1% to £48.2 million and recurring revenue climbing 11%. While organic annual recurring revenue (ARR) declined by 19% due to the loss of a major client, the company made notable gains in its EagleAI product line and added six new blue-chip customers to its portfolio.

Strategic developments included the acquisition of Promotional Payments Solutions, aimed at expanding its capabilities, and the launch of a share buyback program, signaling management’s confidence in future growth. Additionally, Eagle Eye’s global OEM agreement is expected to become a major revenue contributor starting in FY27, reinforcing its medium-term growth trajectory.

The company’s outlook remains broadly positive, supported by healthy financials and successful strategic moves. However, bearish technical trends and the absence of a dividend yield present headwinds in the near term. Favorable valuation indicators and long-term growth potential offer a constructive backdrop if market sentiment improves.

About Eagle Eye Solutions Group PLC

Eagle Eye Solutions is a leading software-as-a-service (SaaS) and artificial intelligence company focused on transforming retail marketing through real-time, personalized digital engagement. The company provides advanced loyalty and promotion solutions to global retailers, enabling data-driven marketing at scale. Its innovative platform supports seamless integration of personalization and AI to enhance customer loyalty and engagement across multiple channels.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Ilika plc (LSE:IKA) has secured £1.25 million in funding from the UK Government’s DRIVE35 initiative to support the production of its Goliath A-Sample batteries designed for electric vehicle applications. The grant is part of a wider £3 million collaborative project involving the High Speed Sustainable Manufacturing Institute (HSSMI) and the UK Battery Industrialisation Centre. The project, known as PRIMED, aims to accelerate the industrialization of Ilika’s solid-state battery technology and strengthen the UK’s leadership in advanced battery innovation.

The funding marks a positive step for Ilika as it continues to scale its Goliath platform, although broader financial challenges and valuation concerns remain a drag on sentiment. While the grant and strategic progress in product development offer encouraging signs, the company’s financial position still presents key risks for investors.

About Ilika plc

Ilika plc is a pioneer in solid-state battery technology, specializing in next-generation energy storage solutions for sectors such as electric vehicles, medical devices, and smart consumer electronics. The company’s product portfolio includes the Stereax line for miniature medical and IoT applications, and the Goliath platform, targeting large-format uses like EVs and power tools. Operating primarily under a licensing model, Ilika provides intellectual property to original equipment manufacturers and partners in exchange for licensing fees and future royalties.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Advanced Medical Solutions Group plc (LSE:AMS) has reported a strong first half for 2025, supported by continued growth in its surgical products segment and the successful integration of recent acquisitions—Peters Surgical and Syntacoll. The company’s strategic restructuring of its Woundcare division has led to improved margins, helping drive expected H1 revenue to approximately £110 million, a notable increase from £68 million in the same period last year. Management remains optimistic about meeting full-year guidance, with additional synergies expected from ongoing integration efforts.

AMS’s financial position and operational momentum point to solid long-term potential. While recent corporate developments have strengthened its growth outlook, challenges in maintaining profitability and a relatively high valuation present some risks. From a technical standpoint, indicators suggest the stock is fairly valued at present, with possible upside if margin improvements and cost efficiencies continue.

About Advanced Medical Solutions Group plc

Advanced Medical Solutions is a UK-based developer and manufacturer of advanced wound care and surgical products, committed to improving healing outcomes and delivering value to healthcare systems. Its product range includes tissue adhesives, sutures, haemostats, internal fixation devices, and sealants, marketed under various proprietary brands. AMS also offers wound care solutions through its ActivHeal® line. Since 2019, the company has expanded through multiple acquisitions and now distributes its products globally via a combination of direct sales and strategic partnerships, with manufacturing operations in several countries.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Robert Walters PLC (LSE:RWA) reported a 13% year-over-year drop in net fee income for the second quarter of 2025, reflecting the impact of heightened global economic uncertainty and softer forward demand in the specialist recruitment sector. In response to these headwinds, the company has taken steps to streamline its operations, including exiting the Brazilian market and simplifying management structures in selected regions.

While trading conditions remain especially tough in Europe, Robert Walters continues to advance its long-term strategic priorities, emphasizing operational efficiency and enhanced talent solutions to support clients during a slow recovery phase.

Looking ahead, the company’s outlook remains cautious. Financial pressure from declining revenue and margin compression weighs heavily on sentiment. Technical indicators point to ongoing negative momentum, further reflecting bearish investor expectations. Despite an attractive dividend yield, concerns over earnings sustainability and valuation persist. However, governance initiatives and performance-linked incentives may help align leadership focus as the company navigates economic challenges.

About Robert Walters PLC

Robert Walters PLC is a global recruitment firm specializing in professional talent acquisition and outsourcing solutions. The company delivers recruitment services across a range of sectors and geographies, with operations spanning the Asia-Pacific region, Europe, the UK, and other international markets.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Genus plc (LSE:GNS) has reported solid full-year results for FY25, with overall group performance meeting expectations. The company saw double-digit growth in adjusted operating profit for its PIC division, supported by a £3.7 million milestone payment tied to the U.S. FDA’s approval of its gene-edited PRRS Resistant Pig. Meanwhile, its ABS division outperformed expectations in the second half, benefiting from the ongoing Value Acceleration Programme, which delivered £8.5 million in efficiencies.

Genus now anticipates its adjusted profit before tax will reach at least £72 million, reflecting improved cash flow and a reduction in leverage. The FDA’s approval represents a landmark achievement in animal biotechnology, strengthening Genus’s position as a global leader in animal genetics and opening the door to future growth opportunities.

Despite these positive developments, the company’s financial outlook remains balanced. While strategic milestones support a favorable long-term narrative, current valuation concerns and mixed technical signals may limit near-term gains.

About Genus plc

Genus plc is a global pioneer in animal genetics, leveraging biotechnology to improve livestock breeding and productivity. The company supplies high-performance genetics to the dairy, beef, and pork industries, primarily through semen, embryos, and breeding stock. It operates under the brands ‘ABS’ (for cattle) and ‘PIC’ (for pigs), with a global footprint spanning more than 25 countries. Headquartered in Basingstoke, UK, Genus also runs advanced research facilities in Madison, Wisconsin, USA.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

GlobalData Plc (LSE:DATA) has delivered a stable performance in the first half of 2025, underpinned by its ongoing Growth Transformation Plan (2024–2026), despite a challenging macroeconomic backdrop. The company is shifting toward a solutions-led sales model and a focus on strategic account management, which has contributed to an increase in forward contracted revenue and a robust client pipeline. During the period, GlobalData completed two acquisitions aimed at strengthening its Consumer Innovation Intelligence offerings.

As part of its capital return strategy, the company has announced a tender offer of up to £60 million. It also plans to transition to a Main Market listing by the fourth quarter of 2025, reinforcing its focus on delivering sustainable shareholder value.

While the company’s operational progress and strategic initiatives support a positive long-term view, technical analysis indicates bearish trends in the short term. Additionally, current valuation levels may be seen as stretched, potentially limiting near-term upside.

About GlobalData Plc

GlobalData Plc is a prominent player in the data and analytics sector, delivering insight-driven solutions across key domains such as sales, competitive, and strategic intelligence. The firm places strong emphasis on consumer innovation intelligence and continues to evolve its technology and service portfolio to meet growing market demand.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Trustpilot Group Plc (LSE:TRST) has reported impressive results for the first half of 2025, with bookings rising 19% and revenue increasing by 21% year-over-year. In light of this strong performance, the company has revised its full-year adjusted EBITDA margin forecast upward to 14%, highlighting the strength of its SaaS-driven model and solid cash flow. As part of its ongoing focus on governance, Trustpilot has also announced the initiation of a competitive selection process to appoint a new external auditor.

The company’s positive momentum, combined with what analysts consider a favorable valuation, points to potential undervaluation of the stock. While technical charts suggest some resistance at higher price levels, Trustpilot’s strong fundamentals and low price-to-earnings ratio offer a compelling case for continued growth.

About Trustpilot Group Plc

Founded in 2007, Trustpilot is a global leader in the online review space, offering a platform where consumers and businesses connect through shared feedback. With a vast database of over 300 million reviews and a monthly audience of 64 million active users, the company operates out of its headquarters in Copenhagen and maintains a presence in several major global markets.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Once again, Donald Trump is talking tough about tariffs, threatening to raise them in dozens of countries, but has not yet acted. Instead, he is leaving space, or rather time, for negotiations. This time, however, the deadline is not three months, but initially three weeks, until August 1.

The markets are barely reacting. Neither the S&P 500, the Nasdaq, or the US dollar index plummeted. Investors seem convinced this is all part of Trump’s usual bluff-and-bargain routine, the now familiar “TACO trade.” It might seem that this game could go on indefinitely without causing real damage.

The uncertainty surrounding US trade policy is one of the key reasons why the Fed has been hesitant to cut rates, despite slowing inflation and pressure from Trump. Not surprisingly, according to CME Group’s FedWatch tool, there is a 93% chance that the Fed will hold rates steady at the July meeting.

Still, investors are betting on two cuts before the end of the year. Hope is driving this market more than logic.

Fear of missing out (FOMO) also helps sentiment, pushing Nvidia to a market cap of $4 trillion, for the first time in history among public companies. Bitcoin also continues to rise, surpassing the $120,000 mark. Now, all eyes are on the upcoming earnings season, which will have to pay off to keep the rally alive.

Analysts are again forecasting a slowdown in earnings growth, just as they did last quarter. But they were wrong then, as most companies beat expectations despite all the trade war noise. This pattern could easily repeat itself, which would help keep bullish sentiment in the US market alive.

Keep in mind also that the effects of trade tensions are not being felt equally across all sectors. Fundamentals seem to remain strong in sectors such as technology, communications, and the defensive sector. Tuesday’s bank earnings reports are also expected to meet, if not exceed, expectations.

The problem is that the U.S. market has been rising for months without a correction, which cannot last forever.